Our findings suggest that young HHCs of TB patients with increased numbers of CD16+CD56+ cells and Tregs as well as decreased production of T4 hormone and IL-1α at baseline are at an increased risk of developing active TB disease. The gene discussed is NCAM1; the disease is tuberculosis.